AstraZeneca Acquires Chinese Generics Firm | Chemical & Engineering News
Volume 89 Issue 51 | p. 23 | Concentrates
Issue Date: December 19, 2011

AstraZeneca Acquires Chinese Generics Firm

Department: Business
Keywords: China, pharmaceuticals, generics

AstraZeneca has agreed to buy Guangdong BeiKang Pharmaceutical, a producer of generic drugs in China’s Guangdong province. AstraZeneca says the acquisition provides a portfolio of injectable drugs used to treat infections. In recent years, multi­national drug companies have been pushing to improve their position in the Chinese drug market, where rising affluence is increasing demand for brand-name medicines. In October, AstraZeneca announced plans to build a $200 million plant in Taizhou, Jiangsu province, that will produce injectable and oral drugs.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment